Tikomed is a company that develops treatments for patients with severe and life-threatening conditions. It focuses on neurological and opthalmic diseases as well as regenerative cell therapies. The company provides IBsolvMIR, an infusion product that inhibits IBMIR and alleviates its detrimental effects when administered during transplantation. It also offers ILB, a pleiotropic molecule that can be used to treat several neurological diseases.